Mulroy Michael H.
SEC insider (Form 3/4/5 filer). CIK 0001509725. Director at Lineage Cell Therapeutics, Inc. (LCTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2026. Located in CARLSBAD, CA.
Companies Mulroy Michael H. has filed insider reports for
- Lineage Cell Therapeutics, Inc. (LCTX): Director
Mulroy Michael H.
CIK: 0001509725
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LCTX
Lineage Cell Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jul 1, 2026LCTX
Lineage Cell Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
125K shares- - Jul 1, 2025LCTX
Lineage Cell Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
75K shares- - Nov 22, 2024LCTX
Lineage Cell Therapeutics, Inc.
PurchaseDirect40K shares at avg. $0.57$23K
1-3 of 3 transactions